Dr. Rabab Tayyem is the Acting Director General of ACDIMA and CEO of ACDIMA Bio Center, with more than 25 years of experience spanning pharmaceutical industry, clinical studies and bioequivalence research. She holds a BSc in Pharmacy, an MSc in Analytical Toxicology and a PhD in Drug Design and Medicinal Chemistry. She has spent more than 17 years at ACDIMA Bio Center in functions centered on regulatory science, bioavailability and bioequivalence studies.